Bio-Bridge Science Receives Approval for Acquisition of Xinheng Baide
July 08 2008 - 8:56AM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
engaged in the commercial development of vaccines for the
prevention and treatment of human infectious diseases announced
today that it had received a certificate of approval from the
Department of Commerce of Inner Mongolia Autonomous Region of the
PRC for approving the acquisition of Xinheng Baide Biotechnology
Co. Ltd. BGES has one month to close the transaction, and obtain
the new business license. The transaction is expected to close
before the end of July. Dr. Liang Qiao, Chairman and CEO of
Bio-Bridge said, �We are happy to see the Inner Mongolia government
has approved our acquisition of Xinheng Baide. The completion of
the acquisition of Xinheng Baide will be a significant first step
of our acquisition strategy. We believe Xinheng Baide will provide
revenues and complementary products to Bio-Bridge.� This press
release contains forward-looking statements. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying
assumptions and other statements that are other than statements of
historical facts. These statements are subject to uncertainties and
risks including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether
made by or on behalf of the company, are expressly qualified by
these cautionary statements and any other cautionary statements
which may accompany the forward-looking statements. In addition,
the company disclaims any obligation to update any forward-looking
statements to reflect events or circumstances after the date
hereof. Please refer to the Company's SEC filings for additional
information.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science, Inc. News Articles